| || Journals||
| || Allergy Asthma Immunology - archive |
| Authority of Polish Society of Allergology
||vol 20. no 4. December 2015
|The qualification of severe asthma patients to the treatment with use of omalizumab - the guide for doctors|
Since 2013 in Poland it has been possible to treat patients with severe allergic
asthma with omalizumab – a monoclonal antibody. The treatment
is reimbursed by the National Health Found. The article explains the rules
applied in qualifying patients to the treatment with omalizumab. Moreover,
indications, contraindications and rules for monitoring patients with
severe asthma treated with omalizumab are presented.
keywords: omalizumab, ciężka astma, refundacja przez NarodowyFundusz Zdrowia,omalizumab, severe asthma, the reimbursement byNational Health Found
pages: from 215 to 217
|estimated time of download (61 kB)|
Copyright © 1996-2020 Mediton Publishing House | All rights reserved.